Stockreport

Evofem Biosciences Reports Positive Top-Line Results from Phase 2b Study of Amphora® for Prevention of Chlamydia and Gonorrhea in Women

Evofem Biosciences, Inc.  (EVFM) 
Last evofem biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: evofem.com